Extracardiac complications of endocarditis influence diagnosis, therapeutic plans, and prognosis. The aim of this study was to assess how early combined cerebral and abdominal magnetic resonance imaging (MRI) affects the diagnosis and management of adults with endocarditis.
Aims
Extracardiac complications of endocarditis influence diagnosis, therapeutic plans, and prognosis. The aim of this study was to assess how early combined cerebral and abdominal magnetic resonance imaging (MRI) affects the diagnosis and management of adults with endocarditis.
Methods and results
In a single-centre prospective study, 58 patients with endocarditis underwent systematic cerebral and abdominal MRI within 7 days following admission. Diagnostic classification (Duke's modified criteria) and therapeutic plans were established by two experts just before and after MRI and then compared. Endocarditis was initially classified as definite in 29 patients, possible in 27, and excluded in 2. MRI detected cerebral lesions in 47 patients (81%) (ischaemic lesions in 25, microbleeds in 32, and silent aneurysms in 6), and abdominal lesions in 20 patients (34%). Based solely on MRI results without taking microbleeds into account, experts upgraded endocarditis diagnostic classification in 8 out of 29 (28%) non-definite endocarditis cases either to definite in 6 or to possible in 2. This upgrading was exclusively due to cerebral MRI in four patients and to cerebral and/or abdominal MRI in four patients. Experts modified endocarditis therapeutic plans in 11 (19%) out of the 58 patients, based solely on cerebral MRI, including modification of surgical plans in six (10%) patients. Overall, early MRI led experts to modify classification and/or therapeutic plans in 16 (28%) patients.
Conclusion
MRI identified cerebral and/or abdominal asymptomatic lesions in many patients with endocarditis, but more frequently cerebral. Both cerebral and abdominal MRI findings affected diagnosis, but only cerebral MRI affected clinical management plans.
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Introduction
Embolic events are frequent complications of infective endocarditis (IE), occurring in 20-50% of the patients, and have an impact on patient's prognosis. 1 -3 Their frequency depends on investigations used since embolic events can be silent and only detected using systematic computed tomography (CT) or echography. 1, 4 Embolic events influence patient management in different settings since they are minor criteria in the Duke classification and may lead to changes in anticoagulant and/or antibiotic therapy and to consideration of valvular surgery during the acute phase of IE. 1 Moreover, embolic events, in particular when cerebral, have their own prognostic value. Embolic events most frequently affect the central nervous system, followed by abdominal locations. 1 In a large series of 384 patients undergoing systematic CT or abdominal echography, embolic events located to the spleen and kidneys were present in 18% of all patients and in 54% of those with embolic events. 3 Systematic search for asymptomatic peripheral emboli is not currently recommended in IE guidelines as their impact on patients care and prognosis has not been evaluated so far. 1, 5 Magnetic resonance imaging (MRI) may be a valuable skill to detect peripheral manifestations of IE as it is more sensitive and less toxic than conventional CT scan. Recent reports have highlighted the high frequency of asymptomatic cerebral lesion using systematic cerebral MRI, 6 -8 but none looked at the existence of combined abdominal asymptomatic lesion using systematic MRI. In the present study, we report the results of a systematic search of peripheral lesions of IE using angio-MRI performed consecutively and assess whether these findings affected the diagnosis and the management of the patients according to their embolic location. 9 
Methods
Design and patients
Patients were included consecutively in this prospective study if they had definite or possible acute IE according to the Duke modified criteria. Patients who did not fulfil the criteria for 'definite or possible IE' conditions at that time (i.e. 'excluded' IE), but with no other confirmed diagnosis, and with suspected IE warranting initiation of antibiotic therapy, could also be included. Exclusion criteria were usual contraindications to MRI, previous cerebral or abdominal MRI during the ongoing episode of IE, unstable vital status contraindicating moving to MRI and/or long stay (1 h) inside the MRI tunnel, or urgent need for surgery. The study was approved by the local Ethics Committee. Written informed consent was obtained from all patients.
Measurements and magnetic resonance imaging interpretation
All patients had standardized clinical examination. Transthoracic and/or transoesophageal echocardiography as clinically indicated was performed in all patients at inclusion using a standardized procedure. Repeated blood cultures and serological tests for microorganisms responsible for IE with negative blood cultures were performed in all patients. Cerebral combined with abdominal MRI had to be performed within 7 days after inclusion and before any surgical intervention. It was performed on a 1.5 T GE system (Milwaukee, WI, USA) using a standardized protocol for brain examination including b1000 s/m 2 diffusion, T2* gradient-recalled imaging (T2*-GRE), T2 FLAIR-weighted sequences, three-dimensional (3D) T1 post-contrast (Dotarem, Guerbet, France) using a 5 mm slice thickness and 0.5 mm slice gap, and magnetic resonance angiography. A 3D T1 fast spoiled gradient-recalled post-contrast sequence with a slice thickness of 8 mm was secondly acquired to explore the abdominal area including the liver, spleen, and kidneys. All radiologists were blinded to patient characteristics. MRI data collected for the brain examination included: recent and old ischaemic lesions, parenchymal haemorrhage, subarachnoidal haemorrhage, brain abscess, microbleeds (also called microhaemorrhages), and aneurysms. Acute infarct was defined on diffusion-weighted images as a hyperintense lesion with restricted apparent diffusion. Haemorrhagic lesions comprised acute and chronic parenchymal and pericerebral bleeding, detected on T2* gradient-recalled and FLAIR sequences. Microbleeds were defined as round T2* hypointensities with diameter ≤10 mm, as described previously. 10, 11 Cerebral abscesses were defined as round expansive lesions with central restricted apparent diffusion, hyperintense peripheral oedema on FLAIR sequence, and post-contrast annular enhancement. Mycotic aneurysms were defined on time-of-flight-weighted and contrast-enhanced magnetic resonance angiography sequences and 3D T1-weighted post-contrast sequence as focal saccular or fusiform enlargement of an intracranial artery. Saccular aneurysms located on the circle of Willis were considered as congenital aneurysms.
Abdominal ischaemic and abscess lesions were, respectively, defined as segmental triangular-shaped defects and round mass effect lesions with no or peripheral enhancement. Parenchymal haematoma was considered when a focal hypersignal mass was present, with or without hyposignal rim. Number, size, and location of lesions were assessed.
Assessment of changes in diagnosis and management
Within 24 h before MRI, two experts in IE (a cardiologist and an infectious disease specialist) examined the patients and filled in a standardized questionnaire concerning IE characteristics and the presence of peripheral complications after standardized examination. They jointly established initial IE classification according to the modified Duke criteria and outlined an antimicrobial therapy plan and, if necessary, a surgery plan (timeline, type of surgery, indications, etc.). Within 24 h following MRI, the same experts jointly reclassified IE and proposed diagnostic and/or therapeutic modifications where appropriate, according to the additional findings of cerebral and abdominal MRI. A final Duke classification was established at discharge taking into account the occurrence of new events and the results of surgery (microbiology, histology), if performed.
Follow-up
Six-month follow-up was performed by phone call to the patient and/ or the referring physician to assess vital status, the performance of valvular surgery, recurrence of IE, and occurrence of new peripheral events.
Statistical analysis
Quantitative variables are expressed as mean + standard deviation and qualitative variables as numbers and percentages.
Results
Study population
Sixty patients were included in the study. The reasons for noninclusion are detailed in Figure 1 . The IE diagnosis was finally excluded in two patients in whom antibiotic therapy was prematurely interrupted and subsequent course confirmed the absence of IE. The 58 remaining patients (39 males and 19 females) constitute the basis of the present study: IE was initially classified as definite in 29 patients (50%), possible in 27 (47%), and excluded in 2 (3%) at the time of inclusion.
Patient characteristics
Patient characteristics are shown in Table 1 . IE developed on a cardiac prosthesis in 17 patients (29%). Four patients (7%) presented with neurological manifestations of IE before MRI was performed (meningitis in one and neurological deficit in three). No patients had clinical abdominal manifestations of IE.
Magnetic resonance imaging results
Abdominal MRI revealed at least one IE-related lesion in 20 patients (34%). Acute ischaemic lesions were detected in 18 (31%) patients and were localized in the spleen in 15 (26%) and/ or in the kidney in 5 (9%), 2 patients having lesions in both spleen and kidneys. Spleen haematoma was detected in two patients (3%). An abscess was detected in three patients (5%) and was localized in the spleen, kidney, and in both the liver and spleen, respectively ( Table 2) .
Cerebral MRI revealed at least one IE-related lesion in 47 patients (81%) (Figures 2 and 3) . All 4 patients with neurological symptoms had abnormal MRI as did 43 out of the 54 (80%) patients without neurological symptoms. Acute ischaemic lesions were detected by diffusion-weighted imaging in 25 out of 58 patients (43%), haemorrhagic lesions in 3 (5%), abscesses in 4 (7%), and microbleeds in 32 (55%). Subarachnoid haemorrhage was detected in five patients (9%). MRI led to suspect a mycotic aneurysm in six patients (10%). All had cerebral arteriography which confirmed aneurysm in three ( Table 3) . When excluding microbleeds, cerebral MRI showed at least one lesion in 43 patients (74%) and 39 (72%) of the 54 patients without neurological symptoms. Three patients had abdominal lesions without cerebral ones.
Overall, cerebral and abdominal MRI detected either cerebral or abdominal IE-related lesions in 50 (86%) patients. Cerebral lesions were present in 17 out of the 20 (85%) patients who had abdominal lesions. Only three patients (5%) had abdominal lesions without cerebral lesions.
Changes in diagnostic classification according to cerebral and/or abdominal magnetic resonance imaging
Without taking into account the cerebral microbleeds which are not included to date as vascular phenomena in the Duke modified classification, cerebral and/or abdominal MRI results led study experts to increase the number of minor Duke's modified criteria in 23 (40%) of the 58 patients. In these 23 patients, this increase was due exclusively to abdominal MRI results in 1, to cerebral MRI results in 11, and to both cerebral and abdominal MRI results in 11. In 8 of these 23 patients (35%; 14% of the 58 patients and 27% of the 30 patients with non-definite IE at inclusion), modification of minor Duke's modified criteria led to upgrading the diagnosis of IE either from 'possible' to 'definite' in 6 patients or from 'excluded' to 'possible' in 2 patients ( Table 4) . In these eight patients, changes in diagnostic classification were never exclusively due to abdominal MRI results. They were exclusively due to cerebral MRI results in four patients and due to both cerebral and abdominal MRI results in four patients.
When considering microbleeds as vascular phenomena in the Duke classification, MRI would have led to modification of the classification of IE in 14 patients (47% of 30 patients with non-definite IE) with 12 patients' Duke classification upgraded from possible to definite and 2 upgraded from excluded to possible. Cerebral MRI results were the only reason for increasing the number of criteria.
For the two patients whose IE diagnosis was initially classified as 'excluded' at inclusion, clinical evolution also led to the upgrading of IE diagnosis classification to 'possible', even without considering MRI results. At discharge, regardless of MRI results, IE was classified as definite in 46 patients (79%) and possible in 12 (21%) (Figure 1 ).
Changes in decisions of therapeutic management according to cerebral and/or abdominal magnetic resonance imaging
Without taking into account microbleeds, cerebral and/or abdominal MRI results led study experts in 11 (19%) of the 58 patients to change medical and/or surgical therapy, but never exclusively based on abdominal MRI results. They were exclusively due to cerebral MRI results in seven patients and due to both cerebral and abdominal MRI results in four patients.
Changes concerned only anticoagulant therapy in two patients, only antimicrobials in three, and surgery plan in 6. Surgery plan modifications consisted in change of surgery timing in all cases (postponed in four and advanced in the two others). In one 
In-hospital outcome and follow-up
Twenty-five patients (43%) underwent valve surgery before hospital discharge: 18 on a native valve and 7 on a prosthetic valve. None of these patients underwent reoperation within 6-month follow-up.
Six-month follow-up was obtained in 57 patients (99%). Six patients (10%) had died at 6 months: five during hospitalization and one after discharge. In operated patients, two died of post-operative multiorgan failure. In non-operated patients, the four causes of death were haemodynamic in three patients including one patient after discharge and neurological in one patient.
Discussion
This study using systematic combined cerebral and abdominal MRI in 58 patients at the early phase of IE shows the presence of IE-related lesions in as many as 86%. Either singly or in association, abdominal lesions were present in 34% of the patients and cerebral lesions in 81% (74% without considering microbleeds), although no patient had abdominal symptoms and only four (7%) had neurological symptoms. These findings had an impact on diagnostic classification and/or clinical decisions in almost one out of three patients, but never on the exclusive basis of abdominal MRI findings.
The frequency of IE-related lesions is consistent with the findings from autopsies which found peripheral lesions of IE in as many as 80 -90% of the patients. 12 More recently, studies using systematic CT scan have shown that peripheral localizations of IE are more frequent than clinical manifestation could lead one to think. 3,4,13 Di Salvo et al. reported asymptomatic peripheral emboli in 8% of the patients, without specifying their cerebral or extra-cerebral locations. However, CT imaging is relatively insensitive for the detection of acute stroke. 14 The 80% cerebral lesion rate in our patients population is consistent with two recent studies of systematic MRI in 40 and 49 patients with IE 6,7 reporting 80 and 55% of lesions, respectively. Thus, the systemic nature of IE manifestation appears not to be restricted to those patients who died but to be a characteristic of many patients with IE.
Abdominal lesions due to IE have been less frequently explored in the literature. In the present series, systematic MRI detected abdominal lesions less frequently than cerebral lesions, in, respectively, 34 and 81% of the patients. The predominance of lesions of the spleen, followed by kidneys, is consistent with previous findings. The largest series using systematic CT scan or echography to detect embolic events reported embolic lesions of the spleen and kidneys in, respectively, 13 and 6% of the patients, while cerebral lesions were found in 16% of them. 3 Cerebral embolic events were reported in 17% and non-cerebral embolic events in 23% of the patients in a cohort of 2781 patients which did not comprise systematic imaging. 2 A retrospective series focusing on splenic involvement estimated that splenic lesions were present in 35% of IE. 15 Although comparison between series should be made with caution, MRI seems to increase the detection of IE-related lesions, in particular embolic events, to a higher extent in cerebral than abdominal locations. The higher rate in cerebral location is Cerebral and abdominal MRI in endocarditis concordant with the main brain blood flow when compared with extracerebral organs, responsible for a higher rate of embolic events in the brain, as observed in cardiac thrombotic causes of emboli, associated with atrial fibrillation or prosthetic valves. Of note, most of the patients with abdominal lesions in the present series also had cerebral lesions. The combination of cerebral and abdominal MRI in the present study had a significant impact on IE classification (27%). However, when comparing the respective impact of each single investigation, the higher number of patients discovered having cerebral lesions when compared with those having abdominal ones led to a higher impact of cerebral MRI. When considering combined cerebral and abdominal MRI performed together, all but three of the 34% of the patients with abdominal lesions also had a cerebral lesion. The incremental information provided by abdominal MRI in addition to cerebral MRI consisted in a minor Duke criterion in only one patient and did not impact either diagnostic classification or therapeutic management. Although microbleeds were frequent in the present study and seem to be more frequently observed in IE, 16 they do not represent a minor Duke criterion and were not taken into account. The discovery of silent lesions had the greatest impact in the 29 (50%) patients with 'non-definite' IE early in treatment, since MRI results provided early confirmation of IE diagnosis according to the Duke criteria in 28% of them, in whom the diagnosis of IE was always confirmed at discharge. Thus, MRI led to an earlier diagnosis of IE in patients presenting without initial criteria for definite IE.
In the present study, MRI results led to change therapeutic plans in 19% of the patients. However, the changes prompted by abdominal MRI findings in four patients were also prompted by cerebral MRI findings. Thus, abdominal MRI did not contribute on its own to any therapeutic change once cerebral MRI had been taken into account. In fact, cerebral MRI results alone led the experts to modify IE therapeutic plans, and abdominal MRI added no incremental information. The lack of incremental impact of abdominal MRI can be related to the fact that most patients who had abdominal lesions also had cerebral lesions, which alone determined changes in the therapeutic plan.
We acknowledge several limitations to our study. First, certain selection biases are inherent to the study design. The exclusion of patients with unstable vital sign or needing emergency cardiac surgery led to the selection of patients with a lower risk of complicated IE, as shown by the low rate of symptomatic embolic events and the relatively low 6-month mortality. However, the potential impact of MRI on diagnosis and therapeutic plans is relevant only in patients who do not present with a straightforward diagnosis of IE and indication for emergency surgery. Secondly, this study was not designed to assess whether changes in diagnostic classifications and therapeutic plans due to MRI findings had an impact on patient outcome, which would have required a larger sample size and a longer follow-up. Finally, the experts may have been influenced in their evaluation of the changes in clinical management decisions due to MRI findings by the study's objective of assessing the impact of MRI.
In conclusion, this prospective study shows that early MRI identified abdominal and/or cerebral abdominal lesions, in particular embolic events, in a large number of patients with IE, although not clinically suspected in most of them. Since cerebral MRI has a strong impact on the management of IE and abdominal MRI has no incremental impact, there is no reason to systematically add abdominal MRI to cerebral MRI evaluation. This is also justified by practical considerations of cost, scheduling, and patient discomfort.
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